[Effects of neuraminidase in pneumococcal infections].
D002570:Ceruloplasmin / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006242:Haptoglobins / Q000378:metabolism; D006801:Humans; D007122:Immunoelectrophoresis; D009438:Neuraminic Acids / Q000378:metabolism; D009439:Neuraminidase / Q000378:metabolism* / Q000494:pharmacology; D010996:Pleural Effusion / Q000201:enzymology; D010998:Pleurisy / Q000201:enzymology; D011008:Pneumococcal Infections / Q000201:enzymology*; D013210:Staphylococcus / Q000201:enzymology / Q000472:pathogenicity; D013296:Streptococcus pneumoniae / Q000201:enzymology / Q000472:pathogenicity; D013582:Synovial Fluid / Q000201:enzymology
D006023:Glycoproteins; D006242:Haptoglobins; D009438:Neuraminic Acids; D002570:Ceruloplasmin; D009439:Neuraminidase
Uber die Wirkung von Neuraminidase bei Pneumokokken-Infektionen.